{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:00:03Z","timestamp":1791219603021,"version":"4.1.0"},"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T00:00:00Z","timestamp":1354752000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0050249","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T21:48:57Z","timestamp":1354830537000},"page":"e50249","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["RNA-Seq of Human Breast Ductal Carcinoma In Situ Models Reveals Aldehyde Dehydrogenase Isoform 5A1 as a Novel Potential Target"],"prefix":"10.1371","volume":"7","author":[{"given":"Hitchintan","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoureh","family":"Sameni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Krawetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie F.","family":"Sloane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond R.","family":"Mattingly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,12,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7150\/jca.2.232","article-title":"Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review","volume":"2","author":"SA Lari","year":"2011","journal-title":"Journal of Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ctrv.2008.03.001","article-title":"Recent advances and current controversies in the management of DCIS of the breast","volume":"34","author":"GH Sakorafas","year":"2008","journal-title":"Cancer treatment reviews"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e4505","DOI":"10.1136\/bmj.e4505","article-title":"Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics","volume":"345","author":"R Jeevan","year":"2012","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1245\/s10434-009-0609-z","article-title":"Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions","volume":"16","author":"RG Pleijhuis","year":"2009","journal-title":"Annals of surgical oncology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/bcr1346","article-title":"Overdiagnosis and overtreatment of breast cancer: rates of ductal carcinoma in situ: a US perspective","volume":"7","author":"AS Kumar","year":"2005","journal-title":"Breast cancer research : BCR"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jncimonographs\/lgq024","article-title":"Ductal carcinoma in situ: risk factors and impact of screening","volume":"2010","author":"BA Virnig","year":"2010","journal-title":"Journal of the National Cancer Institute Monographs"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.bjc.6606021","article-title":"Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease","volume":"104","author":"SE Clark","year":"2011","journal-title":"British journal of cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2008.18.3103","article-title":"Ductal carcinoma in situ: state of the science and roadmap to advance the field","volume":"27","author":"HM Kuerer","year":"2009","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1940-6207.CAPR-10-0337","article-title":"Lapatinib Activity in Premalignant Lesions and HER-2\u2013Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial","volume":"4","author":"A Decensi","year":"2011","journal-title":"Cancer prevention research"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/bcr2923","article-title":"\u2018Omic approaches to preventing or managing metastatic breast cancer","volume":"13","author":"OL Griffith","year":"2011","journal-title":"Breast Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1158\/1940-6207.CAPR-11-0334","article-title":"Targeting the HER\/EGFR\/ErbB Family to Prevent Breast Cancer","volume":"4","author":"LR Howe","year":"2011","journal-title":"Cancer prevention research"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.109.160390","article-title":"Three-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitors","volume":"332","author":"Q Li","year":"2010","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/mp800047v","article-title":"3-D tumor model for in vitro evaluation of anticancer drugs","volume":"5","author":"JL Horning","year":"2008","journal-title":"Molecular pharmaceutics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.pathmechdis.3.121806.151526","article-title":"Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures","volume":"3","author":"C Hebner","year":"2008","journal-title":"Annual review of pathology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1593\/neo.07970","article-title":"p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer","volume":"10","author":"Q Li","year":"2008","journal-title":"Neoplasia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1158\/0008-5472.CAN-09-1043","article-title":"Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ","volume":"69","author":"C Jedeszko","year":"2009","journal-title":"Cancer research"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jnci\/92.14.1185a","article-title":"MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ","volume":"92","author":"FR Miller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref18","first-page":"978","article-title":"Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells","volume":"57","author":"CI Sartor","year":"1997","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cancergencyto.2004.03.013","article-title":"Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines","volume":"155","author":"ZQ Yang","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.0931261100","article-title":"Gene expression profiles of human breast cancer progression","volume":"100","author":"XJ Ma","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1158\/0008-5472.CAN-05-4610","article-title":"Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis","volume":"66","author":"CS Schuetz","year":"2006","journal-title":"Cancer research"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-07-1465","article-title":"Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast","volume":"14","author":"A Vincent-Salomon","year":"2008","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/bcr2157","article-title":"Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma","volume":"10","author":"NP Castro","year":"2008","journal-title":"Breast cancer research : BCR"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2353\/ajpath.2009.090115","article-title":"Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression","volume":"175","author":"LA Emery","year":"2009","journal-title":"The American journal of pathology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.molonc.2010.06.007","article-title":"Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer","volume":"4","author":"AA Muggerud","year":"2010","journal-title":"Molecular oncology"},{"key":"ref26","first-page":"362","article-title":"Molecular markers in ductal carcinoma in situ of the breast","volume":"1","author":"D Porter","year":"2003","journal-title":"Molecular cancer research : MCR"},{"key":"ref27","first-page":"3788","article-title":"Analysis of gene expression in ductal carcinoma in situ of the breast","volume":"8","author":"A Adeyinka","year":"2002","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/bcr1613","article-title":"Classification of ductal carcinoma in situ by gene expression profiling","volume":"8","author":"J Hannemann","year":"2006","journal-title":"Breast cancer research : BCR"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/gb-2009-10-3-r31","article-title":"Integrated analysis of breast cancer cell lines reveals unique signaling pathways","volume":"10","author":"LM Heiser","year":"2009","journal-title":"Genome Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10585-008-9218-7","article-title":"Imaging and quantifying the dynamics of tumor-associated proteolysis","volume":"26","author":"M Sameni","year":"2009","journal-title":"Clinical & experimental metastasis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"S Anders","year":"2010","journal-title":"Genome biology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(02)01001-2","article-title":"The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini","volume":"111","author":"J Debnath","year":"2002","journal-title":"Cell"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Duncan DT, Prodduturi N., Zhang B. (2010). WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics, (Suppl 4): P10.","DOI":"10.1186\/1471-2105-11-S4-P10"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-005-9077-8","article-title":"High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model","volume":"96","author":"MJ Worsham","year":"2006","journal-title":"Breast cancer research and treatment"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1016\/0006-2952(82)90308-2","article-title":"Effects of aldehyde dehydrogenase inhibitors on enzymes involved in the metabolism of biogenic aldehydes in rat liver and brain","volume":"31","author":"E Hellstrom","year":"1982","journal-title":"Biochemical pharmacology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1471-4159.1979.tb02290.x","article-title":"Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase","volume":"32","author":"JW van der Laan","year":"1979","journal-title":"Journal of neurochemistry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","article-title":"The activity of antiepileptic drugs as histone deacetylase inhibitors","volume":"45","author":"S Eyal","year":"2004","journal-title":"Epilepsia"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"M Gottlicher","year":"2001","journal-title":"Embo J"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"CJ Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"R499","DOI":"10.1186\/bcr899","article-title":"Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression","volume":"6","author":"MC Abba","year":"2004","journal-title":"Breast cancer research : BCR"},{"key":"ref41","first-page":"2043","article-title":"Gene expression profiling of ductal carcinomas in situ and invasive breast tumors","volume":"23","author":"A Seth","year":"2003","journal-title":"Anticancer research"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0192623309356447","article-title":"Precancer: sequentially acquired or predetermined?","volume":"38","author":"RD Cardiff","year":"2010","journal-title":"Toxicol Pathol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1046-2023(03)00032-X","article-title":"Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures","volume":"30","author":"J Debnath","year":"2003","journal-title":"Methods"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molonc.2007.02.004","article-title":"The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression","volume":"1","author":"PA Kenny","year":"2007","journal-title":"Mol Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"DC Allred","year":"2012","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/bjs.4878","article-title":"Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ","volume":"92","author":"NL Barnes","year":"2005","journal-title":"The British journal of surgery"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exmp.2001.2366","article-title":"Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2\/neu and hormone receptors","volume":"70","author":"EB Claus","year":"2001","journal-title":"Experimental and molecular pathology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0046-8177(92)90257-4","article-title":"Overexpression of HER-2\/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer","volume":"23","author":"DC Allred","year":"1992","journal-title":"Human pathology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clon.2011.09.008","article-title":"Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence","volume":"24","author":"K Han","year":"2012","journal-title":"Clinical oncology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0959-8049(02)00666-4","article-title":"Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast","volume":"39","author":"E Provenzano","year":"2003","journal-title":"European journal of cancer"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(01)00165-4","article-title":"Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics","volume":"37","author":"A Ringberg","year":"2001","journal-title":"European journal of cancer"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jnci\/djq101","article-title":"Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis","volume":"102","author":"K Kerlikowske","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"key":"ref53","first-page":"561","article-title":"BigH3 protein expression as a marker for breast cancer","volume":"21","author":"GM Calaf","year":"2008","journal-title":"International journal of molecular medicine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2011.04.010","article-title":"TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells","volume":"308","author":"G Wen","year":"2011","journal-title":"Cancer letters"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jcb.22258","article-title":"The cell adhesion nectin-like molecules (Necl) 1 and 4 suppress the growth and tumorigenic ability of colon cancer cells","volume":"108","author":"S Raveh","year":"2009","journal-title":"Journal of cellular biochemistry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/glia.20823","article-title":"Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site","volume":"57","author":"J Gao","year":"2009","journal-title":"Glia"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Yamatoji M, Kasamatsu A, Kouzu Y, Koike H, Sakamoto Y, <etal>et al<\/etal>.. (2011) Dermatopontin: A potential predictor for metastasis of human oral cancer. International journal of cancer Journal international du cancer.","DOI":"10.1002\/ijc.26328"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1134\/S0006297909090053","article-title":"Dermatopontin is expressed in human liver and is downregulated in hepatocellular carcinoma","volume":"74","author":"X Li","year":"2009","journal-title":"Biochemistry Biokhimiia"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-4598-6-17","article-title":"Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer","volume":"6","author":"L Ulazzi","year":"2007","journal-title":"Molecular cancer"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/hmg\/ddr154","article-title":"Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk","volume":"20","author":"H Nan","year":"2011","journal-title":"Human molecular genetics"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2353\/ajpath.2009.090246","article-title":"The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients","volume":"175","author":"DL Barraclough","year":"2009","journal-title":"The American journal of pathology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1038\/onc.2010.228","article-title":"The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers","volume":"29","author":"R Hrstka","year":"2010","journal-title":"Oncogene"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12253-008-9089-x","article-title":"Expression of tight junction protein claudin-4 in basal-like breast carcinomas","volume":"15","author":"J Kulka","year":"2009","journal-title":"Pathology oncology research : POR"},{"key":"ref64","first-page":"515","article-title":"Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression","volume":"23","author":"LY Lee","year":"2008","journal-title":"Histology and histopathology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1073\/pnas.0810617106","article-title":"Lipocalin 2 promotes breast cancer progression","volume":"106","author":"J Yang","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"e39446","DOI":"10.1371\/journal.pone.0039446","article-title":"Down-Regulation of HtrA1 Activates the Epithelial-Mesenchymal Transition and ATM DNA Damage Response Pathways","volume":"7","author":"N Wang","year":"2012","journal-title":"PloS one"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Lee S, Stewart S, Nagtegaal I, Luo J, Wu Y, <etal>et al<\/etal>.. (2012) Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma in Situ to Invasive Breast Cancer. Cancer research.","DOI":"10.1158\/0008-5472.CAN-12-0636"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7150\/jca.4120","article-title":"ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas","volume":"3","author":"B Castellana","year":"2012","journal-title":"Journal of Cancer"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Vargas AC, Reed AE, Waddell N, Lane A, Reid LE, <etal>et al<\/etal>.. (2012) Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast cancer research and treatment.","DOI":"10.1007\/s10549-012-2123-4"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ygeno.2008.08.005","article-title":"Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model","volume":"92","author":"DK Rhee","year":"2008","journal-title":"Genomics"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.3748\/wjg.v16.i46.5874","article-title":"Metabolomics of gastric cancer metastasis detected by gas chromatography and mass spectrometry","volume":"16","author":"JL Chen","year":"2010","journal-title":"World journal of gastroenterology : WJG"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1038\/sj.onc.1208794","article-title":"HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma","volume":"24","author":"B Lucas","year":"2005","journal-title":"Oncogene"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.freeradbiomed.2011.11.033","article-title":"Aldehyde dehydrogenases and cell proliferation","volume":"52","author":"G Muzio","year":"2012","journal-title":"Free radical biology & medicine"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1634\/stemcells.2004-0292","article-title":"Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples","volume":"23","author":"DJ Pearce","year":"2005","journal-title":"Stem cells"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"C Ginestier","year":"2007","journal-title":"Cell stem cell"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-4598-7-87","article-title":"ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells","volume":"7","author":"JS Moreb","year":"2008","journal-title":"Molecular cancer"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","article-title":"Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity","volume":"66","author":"D Chen","year":"2006","journal-title":"Cancer research"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcp.2006.08.016","article-title":"Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients","volume":"73","author":"M Wickstrom","year":"2007","journal-title":"Biochemical pharmacology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentatory","volume":"37","author":"CU Johannessen","year":"2000","journal-title":"Neurochem Int"},{"key":"ref80","first-page":"94","article-title":"Biogenic aldehyde metabolism in rat brain. Differential sensitivity of aldehyde reductase isoenzymes to sodium valproate","volume":"657","author":"SR Whittle","year":"1981","journal-title":"Biochim Biophys Acta"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0050249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:15:25Z","timestamp":1588983325000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0050249"}},"subtitle":[],"editor":[{"given":"Bernard W.","family":"Futscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,6]]},"references-count":80,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0050249","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,6]]}}}